SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP) -- Ignore unavailable to you. Want to Upgrade?

To: Harold Lehman who wrote (1126)12/22/1998 11:17:00 PM
From: Harold Lehman  Respond to of 1501
 
One other thing. I also heard that within the last few days that Yorkton Securities made a price projection of $3.00 for Inflazyme next year. I don't know their track record, but I think that they're a respected Canadian brokerage house, FWIW.

HL



To: Harold Lehman who wrote (1126)12/23/1998 1:43:00 AM
From: jackie  Read Replies (1) | Respond to of 1501
 
Harold,

You said,

<<This involves three different pathologists independently analyzing the slides and then arriving at a conclusion that all of them agree upon.>>

If we know beforehand the pathologists will all arrive at the same conclusion, why not save the time and expense of having them meet at all?

I think you meant something else.

Jack


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News